Leading pharmaceutical business and marketing publication Med Ad News announces the nominees for the 32nd Annual Manny Awards, recognizing the best in healthcare advertising and communications. The 2021 Manny Awards ceremony will be held virtually on Thursday, April 22. Klick Health CEO Lori Grant is being honored as the 2021 Industry Person of the Year.
Ogilvy Health’s Andrew Thorn, EVP, Head of Planning, looks toward what the post-pandemic world will look like.
Sapphire Biotech Chief Clinical Officer Douglas F. Lake, PhD, analyzes neutralizing antibodies in the framework of COVID-19 vaccines.
ExplORer Surgical CEO Jennifer Fried discusses the evolving need for AI and AR technology in the healthcare industry as a whole and the COVID-19 pandemic’s effects on the medical device industry.
PRECISIONvalue SVP Maureen Hennessey and PRECISIONeffect AVP Pam Caputo discuss
the flood of digital disinformation and how health care advocates, SDOH volunteers and professionals can help flatten the curve of what the World Health Organization has called an “infodemic.”
In order to support both quality care and healthy business performance, health systems must not only rise to the current challenge – but also implement recovery strategies which allow them to seamlessly adapt to dynamic conditions going forward – according to O’Mally Monahan, MPH, Sr. Director, Patient Assistance Services, McKesson RxO.
Patientco CEO Bird Blitch discusses pandemic topics including ways in which COVID-19 unveiled the inefficiencies and patient frustrations of the U.S. healthcare system and healthcare providers who were lagging in digital transformation efforts.
Mobiquity’s Steve LoSardo, VP, Healthcare Solutions, discusses the technology trends that will shape 2021.
Med Ad News celebrated the leading agencies/networks and creative excellence in the healthcare communications industry on June 18 with the magazine’s first-ever virtual Manny Awards. For the 31st anniversary of the black-tie gala event, Manny Awards were presented throughout the evening to healthcare agencies and networks achieving excellence across 29 categories.
When patients with a rare disease fail to receive a proper diagnosis, treatment plan, and therapy, they can suffer for years. Failed treatments for these prolonged conditions strain patients, caregivers, and the health ecosystem. In addition to the significant physical and emotional struggles these patients endure, delayed diagnoses for rare diseases can also result in many years of lost revenue for manufacturers.